Preclinical program with potential for disease modifying therapeutic
A license agreement from UCB to Pheno Therapeutics will enable the acceleration of a promising new drug tackling neurological diseases towards clinical development.
Archives for January 13, 2023
Asthma treatment approved by FDA after success of trial program
The US Food and Drug Administration (FDA) has approved AstraZeneca’s asthma treatment, Airsupra after positive results from a global phase 3 clinical trial.